Andere Sprachen Turnstone Biologics Corp.

Aktien

A3EMMR

US90042W1009

TSBX

Realtime-Estimate Cboe BZX Andere Börsenplätze 21:10:59 29.05.2024			% 5 Tage	% 1. Jan.
2,64 ^USD	-2,58 %		-4,23 %	+2,36 %

13.05.	Turnstone Biologics Corp. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
16.04.	Turnstone Biologics Corp. kündigt Änderungen im Vorstand an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	13.05.
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference	08.05.
Turnstone Biologics Appoints William Waddill to its Board of Directors	16.04.
Turnstone Biologics Corp. Announces Board Changes	16.04.
Turnstone Biologics Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21.03.
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21.03.
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights	21.03.
Turnstone Biologics to Participate in Upcoming Investor Conferences	21.02.
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.	20.02.
Turnstone Biologics Corp. Announces Demise of P. Joseph Campisi, Jr., Esq, Chief Legal Officer	20.02.
Certain Common Stock of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17.01.
Certain Stock Options of Turnstone Biologics Corp. are subject to a Lock-Up Agreement Ending on 17-JAN-2024.	17.01.
Turnstone Biologics Falls 11% in Premarket Activity Tuesday After Surging 42% in Previous Regular Trading Session	05.12.
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference	27.11.
Turnstone Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	10.11.
Top Premarket Gainers	03.11.
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03.11.
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting	03.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Turnstone Biologics Corp.

Aktien

A3EMMR

US90042W1009

TSBX

Andere Sprachen

Filter